ghk-cu oral clinical trial Beauty GHK-CU 50mg - Contexx Research
Description
It is legally available for purchase strictly for research purposes under the understanding that it will be used in laboratory settings for scientific investigation, not for human consumption or medical treatment
Preclinical studies showed lipolytic and anti-lipogenic effects, but human trials failed to demonstrate significant weight-loss outcomes
Contact our research team Complete Your Stack Complete Your Performance Stack Metabolic Recomp Stack GLP3-RT + MOTS-C + 5-Amino-1MQ GH Maximizer Stack Tesamorelin + Ipamorelin + CJC-1295 Cognitive Edge Stack Semax + Selank Tesamorelin GHRH Analog $84.99
Retatrutide monotherapy achieved 24.2% weight reduction in phase 2 trials, while cagrilintide combined with semaglutide (CagriSema) reached 22.7%
